FDA Expands Eligibility for Pfizer (PFE) -BioNTech (BNTX) COVID-19 Booster Dose to 16- and 17-Year-Olds
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)